Viatris Inc. (VTRS)
Viatris Inc. (VTRS) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $20.57, down 0.84% on the day, which values the company at $23.58B. Price as of 17 Nov 2026, 17:40 UTC, from Yahoo Finance.
Key facts
- Share price
- $20.57−0.84% today
- Market value
- $23.58B
- Forward P/E
- 7.5×
- Dividend yield
- 2.31%
- Funk Score
- 28/100
- Against its own history
- Well above its usual priceusual price $10.51
- 200-week average
- $11.8574% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Viatris Inc. in more detail
VTRS trades at 7.5× next year's expected earnings, 1.6× sales. Measured against its own history, the price is 96% above what its usual multiples would imply ($10.51) — well above its usual price. It sits 74% above its 200-week average of $11.85.
Over the last five fiscal years Viatris Inc. has compounded revenue 3.9% a year, free cash flow 13.4% a year. Its Funk Score is 28 out of 100 (financial strength 1.4, profitability 3.6, growth 2.9, value 3.3, each out of 10).
In its favour: Share count keeps falling. Worth checking: Altman Z in the distress zone; Revenue is shrinking.
9 of the superinvestors tracked here hold VTRS, including Christopher Davis (5.5% of the portfolio), Anthony Bozza (3.2% of the portfolio), Larry Robbins (3.1% of the portfolio).
Superinvestors holding VTRS
9 of the investors tracked here report a position in their latest 13F filing.
- Christopher Davis Davis Advisors5.54% of portfolio · $1.3B · trimmed · Q3 2026
- Anthony Bozza Lakewood Capital3.24% of portfolio · $60.5M · trimmed · Q3 2026
- Larry Robbins Glenview Capital Management3.13% of portfolio · $156.9M · added · Q2 2026
- Bill Miller (founder) Miller Value Partners2.82% of portfolio · $13M · Q3 2026
- Harry Burn Sound Shore Management2.54% of portfolio · $81.3M · new · Q3 2026
- David Einhorn Greenlight Capital1.13% of portfolio · $44M · added · Q2 2026
- Louis Bacon Moore Capital Management0.31% of portfolio · $11.1M · trimmed · Q3 2026
- Josef Lakonishok LSV Asset Management0.28% of portfolio · $148.6M · trimmed · Q3 2026
- Joel Greenblatt Gotham Asset Management0.16% of portfolio · $69.5M · trimmed · Q2 2026
Health Care companies of similar size
- West Pharmaceutical ServicesWST
- Quest DiagnosticsDGX
- STERISSTE
- InsmedINSM
- United TherapeuticsUTHR
- IncyteINCY
- Tenet HealthcareTHC
- BioNTechBNTX
- Guardant HealthGH
- Alnylam PharmaceuticalsALNY
- Zimmer Biomet HoldingsZBH
- Medpace HoldingsMEDP
Side by side:VTRS vs THC (Viatris Inc. vs Tenet Healthcare)VTRS vs INCY (Viatris Inc. vs Incyte)VTRS vs UTHR (Viatris Inc. vs United Therapeutics)VTRS vs BNTX (Viatris Inc. vs BioNTech)VTRS vs INSM (Viatris Inc. vs Insmed)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Viatris Inc. (VTRS): questions and answers
What is VTRS's PEG ratio?
Viatris Inc.'s PEG ratio is 3.79 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Viatris Inc.'s market cap?
Viatris Inc. is valued at $23.58B at a share price of $20.57.
Is VTRS overvalued or undervalued?
Against its own history, VTRS is well above its usual price: the price is 96% above the $10.51 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is VTRS above its 200-week moving average?
Yes. VTRS is 73.6% above its 200-week average of $11.85. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Viatris Inc. growing?
Over the last five fiscal years Viatris Inc.'s revenue grew 3.9% a year.
Does VTRS pay a dividend?
Yes. Viatris Inc.'s dividend yield is 2.31%, or $0.48 a share a year, paying out 960% of earnings.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Viatris Inc. (VTRS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/VTRS
Underlying data: Yahoo Finance; company filings with the SEC.